Pilkington V, et al. Meta-analysis of the risk of Grade 3/4 or serious clinical adverse events in 12 randomised trials of PrEP (n = 15,678). Abstract O143, HIV/Drug Therapy Glasgow 2018.
CVST-VITT in lage-, midden- en hoge-inkomenslanden
sep 2023 | Neuro-vasculair, Vaccinatie, Virale infecties